|
VCPIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.191900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.182700E-03 |
| Normal-vs-Stage2 |
1.068020E-02 |
| Normal-vs-Stage3 |
3.641900E-04 |
| Normal-vs-Stage4 |
1.970190E-04 |
| Stage1-vs-Stage2 |
6.397200E-01 |
| Stage1-vs-Stage3 |
2.003000E-01 |
| Stage1-vs-Stage4 |
7.319600E-02 |
| Stage2-vs-Stage3 |
6.629800E-01 |
| Stage2-vs-Stage4 |
2.902000E-01 |
| Stage3-vs-Stage4 |
4.404200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.636300E-04 |
| Normal-vs-AfricanAmerican |
2.665200E-01 |
| Normal-vs-Asian |
2.401700E-03 |
| Caucasian-vs-AfricanAmerican |
2.034800E-01 |
| Caucasian-vs-Asian |
7.152400E-01 |
| AfricanAmerican-vs-Asian |
1.436820E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.430100E-04 |
| Normal-vs-Female |
4.161800E-04 |
| Male-vs-Female |
8.842600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.122140E-02 |
| Normal-vs-Age(41-60Yrs) |
5.99849999999291E-05 |
| Normal-vs-Age(61-80Yrs) |
1.395200E-03 |
| Normal-vs-Age(81-100Yrs) |
8.931600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.838100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.818400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.998200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.576800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.954200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.752000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.053000E-01 |
| Classical-VS-Follicular |
1.938000E-02 |
| Classical-VS-Other |
2.367600E-01 |
| Classical-VS-Normal |
4.960600E-03 |
| Tall-VS-Follicular |
6.563000E-01 |
| Tall-VS-Other |
5.158400E-01 |
| Tall-VS-Normal |
1.217910E-02 |
| Follicular-VS-Other |
6.914400E-01 |
| Follicular-VS-Normal |
1.593580E-04 |
| Other-VS-Normal |
4.880300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.011090E-04 |
| Normal-vs-N1 |
5.619800E-04 |
| N0-vs-N1 |
5.292400E-01 |
|
|
